Pricing Log in Create free account

Evogene Ltd. (EVGN) vs Exicure, Inc. (XCUR)

Evogene Ltd. and Exicure, Inc. are both Biotechnology companies. Evogene Ltd. and Exicure, Inc. are of similar size ($6.0M and $5.8M). Exicure, Inc. grew revenue faster over the last twelve months: 2,366.5% against −73.6%. Exicure, Inc. has the higher net margin (0.00% vs −547.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Exicure, Inc. leads on 11 and Evogene Ltd. on 5.

Valuation

Metric EVGN XCUR Biotechnology median
P/E n/m n/m 10.60
P/S 2.06 0.22 9.40
P/B 0.59 5.94 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.55 n/m 0.66
EV/Sales (3.58) 0.19 9.02
Earnings yield (325.00%) (145.05%) (32.88%)
Free cash flow yield (315.60%) (102.61%) (23.13%)

Profitability

Metric EVGN XCUR Biotechnology median
Gross margin (67.59%) 80.08% 68.51%
Operating margin (851.42%) 0.00% 0.00%
Net margin (547.62%) 0.00% 0.00%
Free cash flow margin (650.63%) 0.00% 0.00%
Return on equity (100.03%) (168.37%) (51.96%)
Return on assets (38.31%) (54.98%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EVGN XCUR Biotechnology median
Revenue growth (TTM) (73.63%) 2,366.45% 6.76%
EPS growth (last fiscal year) 62.63% 83.37% 29.88%
Revenue growth, 5-year CAGR 29.94% 33.48% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EVGN XCUR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.57 0.56 4.97
Net debt to EBITDA 1.12 0.99 1.01

Dividend

Metric EVGN XCUR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EVGN XCUR Biotechnology median
Market cap 5.95m 5.83m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack